Antibody-based targeted therapy for gastric cancer

Gastric Cancer

Volumn 8, Issue 4, 2005, Pages 206-208

  Lordick, Florian ^a   Peschel, Christian ^a   Siewert, Jörg Rüdiger ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CANCER ANTIBODY; CAPECITABINE; CETUXIMAB; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; GEFITINIB; IMMUNOGLOBULIN G ANTIBODY; IRINOTECAN; MATUZUMAB; MONOCLONAL ANTIBODY; NIMOTUZUMAB; OXALIPLATIN; PANITUZUMAB; TRASTUZUMAB; UNCLASSIFIED DRUG; VASCULOTROPIN ANTIBODY;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; DRUG MECHANISM; DRUG SENSITIVITY; EDITORIAL; HUMAN; LUNG NON SMALL CELL CANCER; MEDICAL RESEARCH; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SOLID TUMOR; STOMACH ADENOCARCINOMA; STOMACH CANCER; THROMBOEMBOLISM; TREATMENT OUTCOME;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HUMANS; ORGANOPLATINUM COMPOUNDS; STOMACH NEOPLASMS;

EID: 28244488665     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-005-0345-4     Document Type: Editorial

References (16)

1. AD Wagner W Grothe S Behl G Kleber A Grothey J Haerting 2005 Chemotherapy for advanced gastric cancer Cochrane Database Syst Rev 18 CD004064
2. F Lordick JR Siewert 2005 Recent advances in multimodal treatment for gastric cancer: a review Gastric Cancer 8 78 85
3. F Kabbinavar HI Hurwitz L Fehrenbacher NJ Meropol WF Novotny G Lieberman 2003 Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer J Clin Oncol 21 60 5
4. H Hurwitz L Fehrenbacher W Novotny T Cartwright J Hainsworth W Heim 2004 Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2335 42
5. R Midgley D Kerr 2005 Bevacizumab - current status and future directions Ann Oncol 16 999 1004
6. J Baselga CL Arteaga 2005 Critical update and emerging trends in epidermal growth factor receptor targeting in cancer J Clin Oncol 23 2445 59
7. K Maeda YS Chung S Ogawa SM Kang M Ogawa T Sawada 1996 Prognostic value of vascular endothelial growth factor expression in gastric carcinoma Cancer 77 858 63
8. T Yoshikawa A Tsuburaya O Kobayashi M Sairenji H Motohashi S Yonoma 2000 Plasma concentrations of VEGF and bFGF in patients with gastric carcinoma Cancer Lett 153 7 12
9. MA Shah D Ilson DP Kelsen 2005 Thromboembolic events in gastric cancer: high incidence in patients receiving irinotecan- and bevacizumab-based therapy J Clin Oncol 23 2574 6
10. A Gamboa-Dominguez C Dominguez-Fonseca L Quintanilla-Martinez E Reyes-Gutierrez D Green A Angeles-Angeles 2004 Epidermal growth factor receptor expression correlates with poor survival in gastric adenocarcinoma from Mexican patients: a multivariate analysis using a standardized immunohistochemical detection system Mod Pathol 17 579 84
11. T Takehana K Kunitomo S Suzuki K Kono H Fujii Y Matsumoto A Ooi 2003 Expression of epidermal growth factor receptor in gastric cancer Clin Gastroenterol Hepatol 1 438 45
12. J Arribas J Baselga 2005 Who will benefit from treatment against EGFR? Lancet Oncol 6 279 86
13. TJ Lynch DW Bell R Sordella S Gurubhagavatula RA Okimoto BW Brannigan 2004 Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N Engl J Med 350 2129 39
14. M Tanner M Hollmén TT Junttila AI Kapanen S Tommola Y Soini 2004 Amplification of Her-2 in gastric carcinoma: association with topoisomerase IIa gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab Ann Oncol 16 273 8
15. T Takehana K Kunimoto K Kono F Kitahara H Iizuka Y Matsumoto 2002 Status of c-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay Int J Cancer 98 833 7
16. C Rebischung R Barnoud L Stéfani J-L Faucheron M Mousseau 2005 The effectiveness of trastuzumab (Herceptin) combined with chemotherapy for gastric carcinoma with overexpression of the c-erbB-2 protein Gastric Cancer 8 249 252